KPC Pharmaceuticals,Inc. (SHA:600422)
China flag China · Delayed Price · Currency is CNY
12.32
+0.02 (0.16%)
Feb 24, 2026, 3:00 PM CST

KPC Pharmaceuticals,Inc. Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9,3269,50811,99815,81210,7078,379
Market Cap Growth
-23.57%-20.76%-24.12%47.68%27.78%27.75%
Enterprise Value
9,8079,98810,97915,19510,6547,992
Last Close Price
12.3212.5615.5320.1613.5310.34
PE Ratio
26.7827.1718.5129.2427.9416.50
Forward PE
14.1213.0118.2423.0817.5413.16
PS Ratio
1.421.451.431.881.291.01
PB Ratio
1.361.391.781.992.081.70
P/TBV Ratio
2.722.773.593.422.361.96
P/FCF Ratio
--16.4724.5370.37542.13
P/OCF Ratio
--14.8520.9642.1733.30
PEG Ratio
-1.181.181.181.181.18
EV/Sales Ratio
1.491.521.311.801.290.97
EV/EBITDA Ratio
15.9916.2911.3817.7714.3214.07
EV/EBIT Ratio
21.8722.2713.7222.3518.9119.53
EV/FCF Ratio
--15.0723.5770.02517.08
Debt / Equity Ratio
0.250.250.120.110.220.17
Debt / EBITDA Ratio
2.762.760.841.011.481.40
Debt / FCF Ratio
--1.141.407.4953.57
Net Debt / Equity Ratio
-0.16-0.16-0.28-0.15-0.16-0.18
Net Debt / EBITDA Ratio
-1.74-1.74-1.98-1.41-1.13-1.60
Net Debt / FCF Ratio
---2.62-1.86-5.51-58.67
Asset Turnover
--0.680.780.900.97
Inventory Turnover
--2.882.632.722.70
Quick Ratio
--1.221.591.211.12
Current Ratio
--1.562.111.741.77
Return on Equity (ROE)
5.15%5.15%10.22%9.81%7.65%10.76%
Return on Assets (ROA)
--4.02%3.91%3.84%2.99%
Return on Invested Capital (ROIC)
5.73%6.24%11.10%10.05%10.92%8.71%
Return on Capital Employed (ROCE)
--11.20%8.10%10.20%7.60%
Earnings Yield
3.75%3.68%5.40%3.42%3.58%6.06%
FCF Yield
--6.07%4.08%1.42%0.18%
Dividend Yield
2.44%-1.93%0.99%1.18%2.61%
Payout Ratio
--26.62%27.11%60.37%40.10%
Buyback Yield / Dilution
-0.95%-0.95%1.05%-1.36%0.84%0.19%
Total Shareholder Return
1.49%-0.95%2.98%-0.37%2.02%2.80%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.